FORS YVONNE 4
4 · THERALINK TECHNOLOGIES, INC. · Filed Sep 22, 2022
Insider Transaction Report
Form 4
FORS YVONNE
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-16+6,488,851→ 6,488,851 totalExercise: $0.00Exp: 2032-09-16→ Common Stock (6,488,851 underlying)
Footnotes (1)
- [F1]2,595,540 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 3,893,311 stock options will vest ratably on January 1, 2023, January 1, 2024 and January 1, 2025.